Bonus Issues

ZYDUS LIFESCIENCES LTD.

NSE : ZYDUSLIFEBSE : 532321ISIN CODE : INE010B01027Industry : Pharmaceuticals & DrugsHouse : Cadila
BSE953.15-0.35 (-0.04 %)
PREV CLOSE ( ) 953.50
OPEN PRICE ( ) 951.00
BID PRICE (QTY) 952.85 (18)
OFFER PRICE (QTY) 953.70 (43)
VOLUME 10774
TODAY'S LOW / HIGH ( )945.00 958.00
52 WK LOW / HIGH ( )482.55 1031.3
NSE953.302.05 (+0.22 %)
PREV CLOSE( ) 951.25
OPEN PRICE ( ) 951.50
BID PRICE (QTY) 953.30 (60)
OFFER PRICE (QTY) 953.75 (259)
VOLUME 351224
TODAY'S LOW / HIGH( ) 944.50 958.65
52 WK LOW / HIGH ( )484.95 1031.7

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.